These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8326526)

  • 1. The significance of Ki-67, BrdU and OKT9 expression in determination of myelodysplastic syndromes by use of APAAP technique.
    Yi FH; Wang BM; Liu XF
    J Tongji Med Univ; 1993; 13(1):30-3. PubMed ID: 8326526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections.
    Pellegrini W; Facchetti F; Marocolo D; Salvi L; Capucci A; Tironi A; Rossi G
    Histopathology; 1995 Nov; 27(5):397-405. PubMed ID: 8575729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas.
    Mitani S; Tango T; Sonobe Y; Baba N; Nagatani T; Nomoto S; Mori S
    Int J Hematol; 1991 Oct; 54(5):385-93. PubMed ID: 1756249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences.
    Gaglia P; Bernardi A; Venesio T; Caldarola B; Lauro D; Cappa AP; Calderini P; Liscia DS
    Eur J Cancer; 1993; 29A(11):1509-13. PubMed ID: 8217353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies.
    Falini B; Canino S; Sacchi S; Ciani C; Martelli MF; Gerdes J; Stein H; Pileri S; Gobbi M; Fagioli M
    Br J Haematol; 1988 Jul; 69(3):311-20. PubMed ID: 3165668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-cycle analysis detecting endogenous nuclear antigens: comparison with BrdU-in vivo labeling and an application to lung tumors.
    Hayashi Y; Fukayama M; Koike M; Kaseda S; Ikeda T; Yokoyama T
    Acta Pathol Jpn; 1993 Jun; 43(6):313-9. PubMed ID: 8346708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow cells in the DNA-synthesis-phase in the myelodysplastic syndrome and lymphome.
    Wenthzel AM; Porwit A; Lindahl K; Widell S; Reizenstein P
    Med Oncol Tumor Pharmacother; 1992; 9(1):51-5. PubMed ID: 1341321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP].
    Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-S1 and proliferating cell nuclear antigen expression of bone marrow macrophages. Immunohistochemical and morphometric study including reactive (inflammatory) myelitis, secondary aplastic anemia, AIDS, myelodysplastic syndromes and primary (idiopathic) osteomyelofibrosis.
    Titius BR; Thiele J; Schaefer H; Kreipe H; Fischer R
    Acta Haematol; 1994; 91(3):144-9. PubMed ID: 7522384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes.
    Thiele J; Hoffmann I; Bertsch HP; Fischer R
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(1):33-8. PubMed ID: 8105604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen.
    Soyer HP; Smolle J; Smolle-Juettner FM; Kerl H
    Dermatologica; 1989; 179(1):3-9. PubMed ID: 2569990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of proliferative fractions detected by immunohistochemistry with the monoclonal antibodies to bromodeoxyuridine and Ki-67 in malignant lymphomas.
    Kawauchi K; Sato Y; Furuya T; Watanabe S
    Hematol Oncol; 1989; 7(4):257-65. PubMed ID: 2472342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
    Zhang F; Hao Y; Pang W
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
    Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
    J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical evaluation of proliferative activity in human brain tumours.
    Girino M; Riccardi A; Danova M; Gaetani P; Butti G; Giordano M; Cuomo A
    Anal Cell Pathol; 1990 Sep; 2(5):269-75. PubMed ID: 2275874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
    Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of immunocytochemical staining versus Giemsa stain for detecting dysmegakaryopoiesis in myelodysplastic syndromes (MDS).
    Kawaguchi M; Nehashi Y; Aizawa S; Toyama K
    Eur J Haematol; 1990 Feb; 44(2):89-94. PubMed ID: 2318299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies.
    Raza A; Yousuf N; Bohkari SA; Sheikh Y; Akhtar S; Chughtai S; Umerani A; Mehdi SA; Miller MA; Masterson M
    Leuk Res; 1992; 16(3):299-306. PubMed ID: 1560677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of proliferative cells.
    Mokrý J; Nĕmecek S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.